Invention Grant
- Patent Title: ALK7 antagonists and uses thereof
-
Application No.: US17505124Application Date: 2021-10-19
-
Publication No.: US12024563B2Publication Date: 2024-07-02
- Inventor: John Knopf , Ravindra Kumar , Asya Grinberg , Robert Scott Pearsall , Dianne S. Sako , Roselyne Castonguay , Gang Li , Yossi Dagon
- Applicant: Acceleron Pharma Inc.
- Applicant Address: US MA Cambridge
- Assignee: Acceleron Pharma Inc.
- Current Assignee: Acceleron Pharma Inc.
- Current Assignee Address: US MA Cambridge
- Agent John David Reilly; Anna Cocuzzo
- Main IPC: A61K38/17
- IPC: A61K38/17 ; C07K14/71 ; C07K16/28 ; C12N9/12
Abstract:
In certain aspects, the disclosure provides ALK7 antagonists. In certain aspects, these ALK7 antagonists are can be used to improve metabolic parameters in a patient in need thereof. In certain aspects, these ALK7 antagonists can be used to treat or prevent one or more kidney-associated disease or condition in a patient in need thereof. In certain aspects, these ALK7 antagonists can be used to treat or prevent cancer.
Public/Granted literature
- US20220289852A1 ALK7 ANTAGONISTS AND USES THEREOF Public/Granted day:2022-09-15
Information query
IPC分类:
